Class II — Potential Health Hazard

Potential health hazard — use of or exposure to this product may cause temporary or medically reversible adverse health consequences.

A820 myPTM Software Application associated with Medtronic SynchroMed Pump and Recalled by Medtronic Neuromodulation Due to Product complaints were received describing the A820 myPTM...

Date: January 9, 2025
Company: Medtronic Neuromodulation
Status: Ongoing
Source: FDA (Device)

What You Should Do

Stop using this product immediately. Do not consume, use, or distribute it.

Return the product to the place of purchase for a full refund. If you have questions, contact Medtronic Neuromodulation directly.

Affected Products

A820 myPTM Software Application associated with Medtronic SynchroMed Pump and Infusion System.

Quantity: 4365 units

Why Was This Recalled?

Product complaints were received describing the A820 myPTM app taking longer than expected for patients to interact with their implantable pump.

Where Was This Sold?

This product was distributed nationwide across all 50 states.

Affected (51 states)Not affected

About Medtronic Neuromodulation

Medtronic Neuromodulation has 95 total recalls tracked by RecallDetector.

Related Recalls

Data sourced from the FDA (Device). Last updated March 26, 2026. View original report